retinopathy semaglutide provides powerful protection against diabetic retinopathy, the leading cause of blindness in working-age adults, Greek study suggests Semaglutide-eye-catching results

By targeting both the GLP-1 and GIP receptors, tirzepatide helps to: Suppress appetite and cravings: It signals the brain to reduce hunger, helping you feel full sooner and for longer [7][8]

During the rest period (weeks 5 to 8)

A history of severe reflux, bariatric surgery, opioid use, Parkinson disease, scleroderma, gastric outlet obstruction, or long-standing diabetes should raise suspicion for baseline motility impairment

Elevate the affected area when possible

The bottom line At the end of the day, microdosing GLP-1s is just a buzzy way of talking about a different approach to GLP-1s namely, starting (and staying) at the right dose for you, even if its lower than what the manufacturer recommends